EUVIMEDEUVIMED entdecken
Open Access

Molecular Profile of Subungual Melanoma: A MelaNostrum Consortium Study of 68 Cases Reporting BRAF, NRAS, KIT, and TERT Promoter Status

David Millan-Esteban, Zaida García-Casado, Anna Macià, Inés de la Rosa, Clara Torrecilla-Vall-Llossera, Rosa Maria Penin, Esperanza Manrique-Silva, Stefania Pellegrini, Maria Raffaella Biasin, Piera Rizzolo, Alicia Gavillero, Alessandro Di Stefani und 8 weitere

Dermatology · 2024

DOI: 10.1159/000534955 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology, 2024. Verfasst von David Millan-Esteban und 19 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Universidad Católica de València San Vicente Mártir, València, Spain. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Nail Diseases, Telomerase. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Subungual melanoma (SM) is an unusual type of melanocytic tumor affecting the nail apparatus. The mutational prevalence of the most prominently mutated genes in melanoma has been reported in small cohorts of SM, with unclear conclusions on whether SM is different from the rest of melanomas arising in acral locations or not. Hence, the molecular profile of a large series of SM is yet to be described.

Objectives

The aim of this study was to describe the molecular characteristics of a large series of SM and their association with demographic and histopathological features.

Methods

Patients diagnosed with SM between 2001 and 2021 were identified from six Spanish and Italian healthcare centers. The mutational status for BRAF, NRAS, KIT, and the promoter region of TERT (TERTp) were determined either by Sanger sequencing or next-generation sequencing. Clinical data were retrieved from the hospital databases to elucidate potential associations.

Results

A total of 68 SM cases were included. Mutations were most common in BRAF (10.3%) and KIT (10%), followed by NRAS (7.6%), and TERTp (3.8%). Their prevalence was similar to that of non-subungual acral melanoma but higher in SM located on the hand than on the foot.

Conclusions

To date, this study represents the largest cohort of SM patients with data on the known driver gene mutations. The low mutation rate supports a different etiopathogenic mechanism for SM in comparison of non-acral cutaneous melanoma, particularly for SM of the foot.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsNail DiseasesTelomeraseHumansProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-kitPromoter Regions, GeneticMutationDNA Mutational AnalysisMembrane ProteinsGTP Phosphohydrolases

Stichwörter der Autor:innen

MelanomaMutationsSubungual

Substanzen

Proto-Oncogene Proteins B-rafProto-Oncogene Proteins c-kitTERT protein, humanTelomeraseBRAF protein, humanNRAS protein, humanMembrane ProteinsGTP Phosphohydrolases

Autor:innen und Institutionen

  • School of Medicine, Universidad Católica de València San Vicente Mártir, València, Spain.
  • Department of Dermatology, Fundación Instituto Valenciano de Oncología, València, Spain.
  • Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología, València, Spain.
  • Department of Experimental Medicine, Oncological Pathology Group, Institut de Recerca Biomèdica de Lleida, University of Lleida, Lleida, Spain.
  • Department of Dermatology, Hospital Universitari de Bellvitge, Bellvitge, Spain.
  • Pathology Unit, Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy.

Förderung

  • Intramural NIH HHS

Zitieren

APA

Millan-Esteban, D., García-Casado, Z., Macià, A., de la Rosa, I., Torrecilla-Vall-Llossera, C., Penin, R. M., Manrique-Silva, E., Pellegrini, S., Biasin, M. R., Rizzolo, P., Gavillero, A., Di Stefani, A., Pellegrini, C., Requena, C., Fargnoli, M. C., Peris, K., Cota, C., Menin, C., Landi, M. T., & Nagore, E. (2024). Molecular Profile of Subungual Melanoma: A MelaNostrum Consortium Study of 68 Cases Reporting BRAF, NRAS, KIT, and TERT Promoter Status. Dermatology. https://doi.org/10.1159/000534955

Vancouver

Millan-Esteban D, García-Casado Z, Macià A, de la Rosa I, Torrecilla-Vall-Llossera C, Penin RM, et al. Molecular Profile of Subungual Melanoma: A MelaNostrum Consortium Study of 68 Cases Reporting BRAF, NRAS, KIT, and TERT Promoter Status. Dermatology. 2024. doi:10.1159/000534955

BibTeX
@article{MillanEsteban2024,
  author = {Millan-Esteban, David and García-Casado, Zaida and Macià, Anna and de la Rosa, Inés and Torrecilla-Vall-Llossera, Clara and Penin, Rosa Maria and Manrique-Silva, Esperanza and Pellegrini, Stefania and Biasin, Maria Raffaella and Rizzolo, Piera and Gavillero, Alicia and Di Stefani, Alessandro and Pellegrini, Cristina and Requena, Celia and Fargnoli, Maria Concetta and Peris, Ketty and Cota, Carlo and Menin, Chiara and Landi, Maria Teresa and Nagore, Eduardo},
  title = {Molecular Profile of Subungual Melanoma: A MelaNostrum Consortium Study of 68 Cases Reporting BRAF, NRAS, KIT, and TERT Promoter Status},
  journal = {Dermatology},
  year = {2024},
  doi = {10.1159/000534955}
}
Kostenlos starten →